MeVac variants encoding a murine version of the IL-15/IL-15Rα fusion protein (FmIL-15) were cloned and their immunomodulatory and anti-tumor activity was compared to MeVac FmIL-12 in two immunocompetent mouse models of measles oncolysis. This evidence concerns the gene IL15 and neoplasm.